Tech Company Financing Transactions
NxThera Funding Round
NxThera, based in Maple Grove, secured $18.2 million from private investors.
Transaction Overview
Company Name
Announced On
8/15/2013
Transaction Type
Venture Equity
Amount
$18,200,000
Round
Series C
Investors
Proceeds Purpose
NxThera will use this Series C capital to (i) conduct a U.S. clinical trial to seek FDA clearance to market its Rezum System to treat BPH, (ii) begin targeted, early commercialization of its Rezum System in selected European countries in 2014, and (iii) expand its applied research and feasibility studies to evaluate applications of its sterile water vapor technology to treat prostate cancer and kidney cancer.
Company Information
Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
7351 Kirkwood Lane N 138
Maple Grove, MN 55369
USA
Maple Grove, MN 55369
USA
Phone
Website
Email Address
Overview
NxThera develops medical technologies to treat a variety of endourology conditions, including BPH. The company's technology platform utilizes a simple, minimally invasive, vapor therapy designed to measurably improve urinary flow and patient quality of life.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Paulson
Chief Financial Officer
Carmen Bringgold
Chief Marketing Officer
Michael Kujak
Chief Operating Officer
Maximillian Fiore
Chief Technical Officer
Michael Hoey
VP - Engineering
Tim Byland
VP - Product Management
Mona Dahdah
Browse more venture capital transactions:
Prev: 8/15/2013: Drync venture capital transaction
Next: 8/15/2013: Moven venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to document all VC transactions involving tech companies. VC transactions reported here come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs